Heart Failure Clinical Trials
Randomized Evaluation of Bromocriptine in Myocardial Recovery Therapy (REBIRTH) for Peripartum Cardiomyopathy
The purpose of the study is to test the use of a drug called bromocriptine for women who have a condition called “Peripartum cardiomyopathy” or PPCM. PPCM means you have a weak heart after giving birth. The study will look at how the heart muscle improves in women taking bromocriptine compared to a group of women given a placebo or inactive pill.
Principal Investigator: Sarah Thordsen, MD
Primary Study Coordinator: Shelley Schultz, CRC III
Status: Currently enrolling
Sub-Category: Advanced Heart Failure
ClinicalTrials.gov Identifier: NCT05180773
Meet Our Team
Sarah E. Thordsen, MD, FACC
Associate Professor
Cardiovascular Clinical Trials
The Cardiovascular Research Service is currently conducting drug and/or device trials in the cardiac subspecialties listed. However, this does not limit what we may be working on tomorrow.
Please contact the Cardiovascular Trials program by calling (414) 955-6784 or at DOMCVClinTriStaff@mcw.edu.